Suppr超能文献

全长重组朊蛋白的纯化与纤维化

Purification and Fibrillation of Full-Length Recombinant PrP.

作者信息

Makarava Natallia, Savtchenko Regina, Baskakov Ilia V

机构信息

Department of Anatomy and Neurobiology, Center for Biomedical Engineering and Technology, University of Maryland School of Medicine, 111 Penn St., Baltimore, MD, 21201, USA.

出版信息

Methods Mol Biol. 2017;1658:3-22. doi: 10.1007/978-1-4939-7244-9_1.

Abstract

Misfolding and aggregation of prion protein are related to several neurodegenerative diseases in humans such as Creutzfeldt-Jakob disease, fatal familial insomnia, and Gerstmann-Straussler-Scheinker disease. A growing number of applications in the prion field including assays for detection of PrP and methods for production of PrP de novo require recombinant prion protein (PrP) of high purity and quality. Here, we report an experimental procedure for expression and purification of full-length mammalian prion protein. This protocol has been proved to yield PrP of extremely high purity that lacks PrP adducts, oxidative modifications, or truncation, which is typically generated as a result of spontaneous oxidation or degradation. We also describe methods for preparation of amyloid fibrils from recombinant PrP in vitro. Recombinant PrP fibrils can be used as a noninfectious synthetic surrogate of PrP for development of prion diagnostics including generation of PrP-specific antibody.

摘要

朊病毒蛋白的错误折叠和聚集与人类的几种神经退行性疾病有关,如克雅氏病、致死性家族性失眠症和格斯特曼-施特劳斯勒-谢inker病。朊病毒领域越来越多的应用,包括检测PrP的分析方法和从头生产PrP的方法,都需要高纯度和高质量的重组朊病毒蛋白(PrP)。在这里,我们报告了一种全长哺乳动物朊病毒蛋白表达和纯化的实验程序。该方案已被证明能产生极高纯度的PrP,且缺乏PrP加合物、氧化修饰或截断,这些通常是自发氧化或降解的结果。我们还描述了体外从重组PrP制备淀粉样纤维的方法。重组PrP纤维可以用作PrP的非感染性合成替代物,用于开发朊病毒诊断方法,包括产生PrP特异性抗体。

相似文献

1
Purification and Fibrillation of Full-Length Recombinant PrP.
Methods Mol Biol. 2017;1658:3-22. doi: 10.1007/978-1-4939-7244-9_1.
2
Purification and fibrillation of full-length recombinant PrP.
Methods Mol Biol. 2012;849:33-52. doi: 10.1007/978-1-61779-551-0_4.
3
Analysis of Prion Protein Structure Using Nuclear Magnetic Resonance Spectroscopy.
Methods Mol Biol. 2017;1658:35-49. doi: 10.1007/978-1-4939-7244-9_4.
4
Expression and purification of full-length recombinant PrP of high purity.
Methods Mol Biol. 2008;459:131-43. doi: 10.1007/978-1-59745-234-2_10.
6
Methods for conversion of prion protein into amyloid fibrils.
Methods Mol Biol. 2008;459:105-15. doi: 10.1007/978-1-59745-234-2_8.
7
A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
Prion. 2018;12(5-6):280-300. doi: 10.1080/19336896.2018.1525254. Epub 2018 Oct 9.
8
Multiple affinity purification of a baculovirus-derived recombinant prion protein with in vitro ability to convert to its pathogenic form.
Prep Biochem Biotechnol. 2017 Jan 2;47(1):1-7. doi: 10.1080/10826068.2016.1155058. Epub 2016 Feb 26.
10
A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a β-sheet rich oligomer.
Biochem Biophys Res Commun. 2018 Nov 17;506(1):81-86. doi: 10.1016/j.bbrc.2018.10.075. Epub 2018 Oct 16.

引用本文的文献

1
Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease.
Cell Tissue Res. 2023 Apr;392(1):301-306. doi: 10.1007/s00441-022-03715-9. Epub 2022 Dec 20.
2
High-Pressure Response of Amyloid Folds.
Viruses. 2019 Feb 28;11(3):202. doi: 10.3390/v11030202.

本文引用的文献

1
Two amyloid States of the prion protein display significantly different folding patterns.
J Mol Biol. 2010 Jul 23;400(4):908-21. doi: 10.1016/j.jmb.2010.05.051. Epub 2010 May 27.
2
Recombinant prion protein induces a new transmissible prion disease in wild-type animals.
Acta Neuropathol. 2010 Feb;119(2):177-87. doi: 10.1007/s00401-009-0633-x. Epub 2010 Jan 6.
3
Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates.
Prion. 2009 Oct-Dec;3(4):224-35. doi: 10.4161/pri.3.4.10112. Epub 2009 Oct 16.
5
The same primary structure of the prion protein yields two distinct self-propagating states.
J Biol Chem. 2008 Jun 6;283(23):15988-96. doi: 10.1074/jbc.M800562200. Epub 2008 Apr 8.
6
Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size.
J Mol Biol. 2008 Feb 29;376(4):1155-67. doi: 10.1016/j.jmb.2007.12.053. Epub 2008 Jan 3.
7
Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay.
J Biol Chem. 2006 Jun 2;281(22):15536-45. doi: 10.1074/jbc.M601349200. Epub 2006 Mar 27.
8
Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core.
J Biol Chem. 2006 Jan 27;281(4):2373-9. doi: 10.1074/jbc.M510840200. Epub 2005 Nov 28.
10
Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Biochemistry. 2005 May 10;44(18):6776-87. doi: 10.1021/bi050251q.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验